Portfolio company
Biosurfit
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops and manufactures point-of-care diagnostic blood tests and instruments for healthcare providers and medical device companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NOWDiagnostics
This company develops and manufactures rapid over-the-counter and point-of-care diagnostic tests for consumers and healthcare professionals.
BioSpeedia
This company develops and produces rapid diagnostic kits for infectious diseases for health professionals and clinical diagnostic markets.
The Binding Site
This company manufactures medical diagnostic assays and instruments for clinicians and laboratory professionals to detect and monitor blood cancers and immune system disorders.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Upfront Diagnostics
The company develops rapid point-of-care blood tests for stroke identification, serving paramedics, emergency medical services, and hospital clinicians.
Radisens Diagnostics
This company develops point-of-care diagnostic platforms for rapid blood testing and chronic disease monitoring, serving healthcare providers such as general physicians and hospitals.
Fida Biosystems
This company develops biophysical analysis platforms for characterising proteins and nanoparticles, serving researchers, biotechnology firms, and pharmaceutical manufacturers to accelerate drug development.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
